Bulletin
Investor Alert

New York Markets Close in:

Gamida Cell Ltd.

NAS: GMDA

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:12 p.m.

/zigman2/quotes/207657083/composite

$

1.74

Change

+0.12 +7.41%

Volume

Volume 959,295

Real time quotes

/zigman2/quotes/207657083/composite

Previous close

$ 1.62

$ 1.74

Change

+0.12 +7.41%

Day low

Day high

$1.60

$1.79

Open

52 week low

52 week high

$1.47

$4.72

Open

Shai Lankry

Presently, Shai Lankry is Chief Financial Officer at Gamida Cell Ltd.

He previously occupied the position of Finance Director for West Pharmaceutical Services, Inc., Chief Financial Officer of Macrocure Ltd., Finance Director-Biologics Cluster at OMRIX Biopharmaceuticals, Inc., Senior Associate at Kesselman & Kesselman and Senior Associate at PricewaterhouseCoopers (Israel).

He received an MBA from Tel-Aviv University.

Transactions

Date Shares Transaction Value
01/28/2022 43,000   Award at $0 per share. 0

Officers and Executives

Mr. Robert I. Blum
Chairman
Dr. Julian Adams
Chief Executive Officer & Director
Mr. Michele I. Korfin
Chief Operating & Commercial Officer
Mr. Shai Lankry
Chief Financial Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Tzvi Palash
Chief Manufacturing Officer
Dr. Anat Cohen-Dayag
Director
Dr. Naama Halevi-Davidov
Director
Dr. Ivan M. Borrello
Director
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Chief of Staff
Dr. Jas Uppal
Chief Regulatory & Quality Officer
Ms. Shawn Cline Tomasello
Independent Director
Mr. Stephen T. Wills
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.